ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 149501 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 149501; 2) Community: the network communities that were significantly associated with the response to NSC 149501; 3) Molecule: the relationships between components within communities and NSC 149501; 4) MDR: the compounds that were significantly associated with the NSC 149501.

NSC Compound Enrichment Correlation
NSC 37186 Null 0.00050783792452736 0.13525602
NSC 176323 Camptothecin Derivative 0.000568922785167321 0.46713609
NSC 357704 Cyanomorpholinodoxorubicin 0.000602374785885765 0.6345008
NSC 623081 Null 0.000982682177273506 0.29269131
NSC 681632 Camptothecin Derivative 0.00116011782209856 0.58897904
NSC 328186 3',4',5'-trimethoxy-3-hydroxy flavone 0.00209154338952974 0.43965529
NSC 606699 Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt 0.00243861794188205 0.22876765
NSC 663792 Null 0.00243861794188205 0.67288492
NSC 668490 Null 0.00243861794188205 0.5157852
NSC 709358 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol 0.00243861794188205 0.46906148
Total:29  Current:1    [First] [Prev] [Next] [Last]